Preventive strategies in VAP: Focus on silver-coated endotracheal tubes

Biomaterials Associated Infection: Immunological Aspects and Antimicrobial Strategies

Volumn 9781461410317, Issue , 2013, Pages 531-555

  Kollef, Marin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTENSIVE CARE UNITS; METAL IONS; TUBES (COMPONENTS); VENTILATION;

CHLORHEXIDINE; CLINICAL STUDY; GEORGIA; HYDROPHILIC POLYMERS; PREVENTIVE STRATEGIES; RELATIVE RISKS; RISKS REDUCTION; SILVER IONS; SILVER SULFADIAZINES; VENTILATOR-ASSOCIATED PNEUMONIA;

SILVER;

EID: 84907842579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1031-7_21     Document Type: Chapter

References (63)

1. Rosenthal VD, Maki DG, Salomao R, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582-91.
2. Rosenthal VD, Maki DG, Jamulitrat S et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control. 2010;38:95-104 e102.
3. Anderson DJ, Kirkland KB, Kaye KS, et al. Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol. 2007;28: 767-73.
4. Kuti EL, Patel AA, Coleman CI. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care. 2008;23:91-100.
5. Michael S. Niederman, Donald E, et al. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
6. File Jr TM. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines. Clin Infect Dis. 2010;51 Suppl 1: S42-7.
7. Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S31-40.
8. Muscedere J, Dodek P, Keenan S, Fowler R, Cook D, Heyland D. Comprehensive evidencebased clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment. J Crit Care. 2008;23:138-47.
9. Rotstein C, Evans G, Born A, et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol. 2008;19: 19-53.
10. Torres A, Ewig S, Lode H, Carlet J. De fining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med. 2009;35:9-29.
11. Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 2008;62: 5-34.
12. Kollef M. SMART approaches for reducing nosocomial infections in the intensive care unit. Chest. 2008;134:447-56.
13. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest. 2006;130:251-60.
14. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520-532.
15. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470-485.
16. Edwards JR, Peterson KD, Mu Y et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37:783-805.
17. Cook D. Ventilator associated pneumonia: perspectives on the burden of illness. Intensive Care Med. 2000;26 Suppl 1:S31-7.
18. Rello J, Lorente C, Bodi M, Diaz E, Ricart M, Kollef MH. Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. Chest. 2002;122:656-61.
19. Ricart M, Lorente C, Diaz E, Kollef MH, Rello J. Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia. Crit Care Med. 2003;31:2693-6.
20. Cason CL, Tyner T, Saunders S, Broome L. Nurses? implementation of guidelines for ventilatorassociated pneumonia from the Centers for Disease Control and Prevention. Am J Crit Care. 2007;16:28-36. discussion 37; quiz 38.
21. Kaynar AM, Mathew JJ, Hudlin MM, et al. Attitudes of respiratory therapists and nurses about measures to prevent ventilator-associated pneumonia: a multicenter, cross-sectional survey study. Respir Care. 2007;52:1687-94.
22. Cook D, Ricard JD, Reeve B, et al. Ventilator circuit and secretion management strategies: a Franco-Canadian survey. Crit Care Med. 2000;28:3547-54.
23. Cabana MD, Rand CS, Powe NR, et al. Why don?t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-65.
24. Zack JE, Garrison T, Trovillion E, et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med. 2002;30:2407-12.
25. Babcock HM, Zack JE, Garrison T, et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest. 2004;125:2224-31.
26. Apisarnthanarak A, Pinitchai U, Thongphubeth K, et al. Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis. 2007;45:704-11.
27. Berwick DM, Calkins DR, McCannon CJ, Hackbarth AD. The 100,000 lives campaign: setting a goal and a deadline for improving health care quality. JAMA. 2006;295:324-7.
28. Zilberberg MD, Shorr AF, Kollef MH. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med. 2009;37:305-9.
29. Bird D, Zambuto A, O?Donnell C, et al. Adherence to ventilator-associated pneumonia bundle and incidence of ventilator-associated pneumonia in the surgical intensive care unit. Arch Surg. 2010;145:465-70.
30. Hawe CS, Ellis KS, Cairns CJ, Longmate A. Reduction of ventilator-associated pneumonia: active versus passive guideline implementation. Intensive Care Med. 2009;35:1180-6.
31. Bouadma L, Mourvillier B, Deiler V, et al. A multifaceted program to prevent ventilator-associated pneumonia: impact on compliance with preventive measures. Crit Care Med. 2010;38:789-96.
32. Zaydfudim V, Dossett LA, Starmer JM, et al. Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle. Arch Surg. 2009;144:656-62.
33. Morrow LE, Kollef MH. Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation. Crit Care Med. 2010;38: S352-62.
34. Shorr AF, Micek ST, Jackson Jr WL, Kollef MH. Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med. 2007;35: 1257-62.
35. Petering HG. Pharmacology and toxicology of heavy metals: silver. Pharmacol Ther. 1976;1: 127-30.
36. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloycoated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. 1998;105:236-41.
37. Ahearn DG, Grace DT, Jennings MJ, et al. Effects of hydrogel/silver coatings on in vitro adhesion to catheters of bacteria associated with urinary tract infections. Curr Microbiol. 2000;41:120-5.
38. Gabriel MM, Sawant AD, Simmons RB, Ahearn DG. Effects of silver on adherence of bacteria to urinary catheters: in vitro studies. Curr Microbiol. 1995;30:17-22.
39. Chandra J, Patel JD, Li J, et al. Modi fication of surface properties of biomaterials influences the ability of Candida albicans to form bio films. Appl Environ Microbiol. 2005;71: 8795-801.
40. Cunliffe D, Smart CA, Alexander C, Vulfson EN. Bacterial adhesion at synthetic surfaces. Appl Environ Microbiol. 1999;65:4995-5002.
41. Patel JD, Ebert M, Ward R, Anderson JM. S. epidermidis bio film formation: effects of biomaterial surface chemistry and serum proteins. J Biomed Mater Res A. 2007;80:742-51.
42. Tebbs SE, Elliott TS. Modi fication of central venous catheter polymers to prevent in vitro microbial colonisation. Eur J Clin Microbiol Infect Dis. 1994;13:111-7.
43. Berra L, De Marchi L, Yu ZX, Laquerriere P, Baccarelli A, Kolobow T. Endotracheal tubes coated with antiseptics decrease bacterial colonization of the ventilator circuits, lungs, and endotracheal tube. Anesthesiology. 2004;100:1446-56.
44. Berra L, Curto F, Li Bassi G, et al. Antimicrobial-coated endotracheal tubes: an experimental study. Intensive Care Med. 2008;34:1020-9.
45. Berra L, Kolobow T, Laquerriere P, et al. Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med. 2008;34:1030-7.
46. Rello J, Afessa B, Anzueto A, et al. Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation. Crit Care Med. 2010;38:1135-40.
47. Olson ME, Harmon BG, Kollef MH. Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. Chest. 2002;121:863-70.
48. Grier N. Silver and its compounds. In: Block SS, editor. Disinfection, sterilization, and preservation. 2nd ed. Philadelphia: Lea & Febiger; 1997. p. 395-407.
49. Rello J, Kollef M, Diaz E, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med. 2006;34:2766-72.
50. Perrelli G, Piolatto G. Tentative reference values for gold, silver and platinum: literature data analysis. Sci Total Environ. 1992;120:93-6.
51. Wan AT, Conyers RA, Coombs CJ, Masterton JP. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem. 1991;37:1683-7.
52. Feldman C, Kassel M, Cantrell J, et al. The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J. 1999;13:546-51.
53. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia. The NASCENT Randomized Trial. JAMA. 2008;300: 805-14.
54. Afessa B, Shorr AF, Anzueto AR, Craven DE, Schinner R, Kollef MH. Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest. 2010;137:1015-21.
55. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis. 1989;139:877-84.
56. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281-8.
57. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest. 1995;108:1655-62.
58. Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa . Clin Infect Dis. 1996;23:973-8.
59. Shorr AF, Zilberberg MD, Kollef M. Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol. 2009;30:759-63.
60. Morrow LE, Jarrett JE, Malesker MA, Kollef MH. Systematic use of a silver-coated endotracheal tube reduces rates of venitlator-associated pneumnia (poster 2146). San Diego, CA: American Thoracic Society International Conference; 2009.
61. Morrow LE, Jarrett JE, Malesker MA, Kollef MK. Effect of a silver-coated endotracheal tube on ventilator-associated pneumonia and medical resource utilization in clinical practice (poster 388). Society of Critical Care Medicine's 39th Critical Care Congress. Miami Beach, FL, 2010
62. Morrow LE, Mintz EP, Malesker MA. Effect of a silver-coated endotracheal tube on ventilatorassociated pneumonia and medical resource utilization in clinical practice (poster 983). Fifth Decennial International Conference on Healthcare-Associated Infections. Atlanta, GA, 2010
63. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilatorassociated pneumonia: a systematic review. Crit Care Med. 2005;33:2184-93.